Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized, Multi-center Study to Assess the Safety and Efficacy of Mucosta (Rebamipide), in Combination With Omeprazole as Adjuvant Therapy in Gastric Ulcer Patients

NCT01150162 is registered in ClinicalTrials.gov with Otsuka Pakistan Limited as lead sponsor.

NCT NCT01150162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01150162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized, Multi-center Study to Assess the Safety and Efficacy of Mucosta (Rebamipide), in Combination With Omeprazole as Adjuvant Therapy in Gastric Ulcer Patients
Lead sponsor
Otsuka Pakistan Limited
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2010
Completion date
August 31, 2012
Enrollment
129 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

gastric ulcer